out of the labyrinth

GST’s attack on pharma’s weakest link: distribution

Age: 30. Nature: Unpredictable. Size: 80,000+. Status: Diminished by 25%, in just 15 months. Prognosis: Pharma distribution is under the scalpel

Ruhi Kandhari, 21 Sep 2018

Since GST was implemented, India’s labyrinthine drug distribution network has begun to change rapidly

The majority of large carry and forwarding agents and small distributors have lost business

The supply chain is now simplifying, with e-pharmacies and private equities like Everstone Capital developing their own supply chains

As drug manufacturers get closer to patients, drugs are getting more accessible. But can they get more affordable?

At least once a month, Bhavik Kumar, founder and CEO of Medibox, gets a panicked call. The callers are worried Indian medicine distributors, desperate to either shut down or get acquired. As the head of Medibox, a digital platform for e-marketing, e-procurement and e-distribution of medicines and healthcare products, Kumar is in a unique position. While, on the one hand, his platform helps connect distributors to pharmacies, the network he has created means that Kumar is able to help connect these beleaguered distributors to potential buyers.

AUTHOR

Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Available exclusively to subscribers of The Ken India

This story is a part of The Ken India edition. Subscribe. Questions?

What sets The Ken apart?

Others tell you what. We tell you the ‘So What?’

Read articles that decode the most significant shifts happening around business, technology, startups and healthcare. 1000+ articles for subscribers of the India edition. 150+ articles for subscribers of the Southeast Asia edition. Plus premium newsletters that help you make sense of the world around you.

Narratives that help you connect the dots

Curated collections of our best articles organised by companies, sectors or transformations.

Become part of an active community

Tens of thousands of subscribers, working at the world’s most successful companies, have made The Ken into a daily reading habit.

So much journalism in India is superficial.

Articles are generic, almost cookie-cutter in their approach. And they don’t provide enough context on the issues they cover. The Ken is different. I don’t always agree with everything they say but I appreciate their commitment to publishing deeply reported narratives and investigations. Their reporters find new ways to analyze tech among other industries. And that’s always worth a read.

Sid Talwar / Co-Founder and Partner / Lightbox Venture Capital

As entrepreneurs, we thrive on being in the know at all times.

A personal subscription to The Ken was a no brainer. But as startup founders, this isn't enough. Team members also need to be in the know, for everyone handles customer-facing responsibilities and an ecosystem change that impacts customers also impacts us

Kiran Jonnalagadda / Co-founder / HasGeek and Internet Freedom Foundation

This is a brilliant piece. Very well researched and explained.

The policy & execution is in quite a mess. the flip flops on KYC, the insidious use (& abuse) of consent, the hopeless competition with zero-balance Jan Dhan accounts - all brought out starkly. Congratulations!

Ajit Ranade / Chief Economist / Aditya Birla Group

Thanks to The Ken, we have articulate, original & relevant stories

that shape our understanding of businesses around us. With placements around the corner, Ken is a great resource to prepare and ace our interviews.

Sandeep Ganesh / Student Body President / ISB 2018

An article from The Ken has become an intrinsic part of my daily news diet.

Nandan Nilekani / Former Chairman / UIDAI

I look forward to Ken's incisive reporting, rigorous research, and contrarian but always logical viewpoints

Deep Kalra / Group CEO / MakeMyTrip

The Ken is my daily guide to intelligent business journalism like never before.

Kapil Chopra / Former President / Oberoi Hotels

Unlock a world of subscriber privileges.
Subscribe now

Exclusive Access

Read 1000+ stories in the Indian edition

App access

Get access to our subscriber-only Android and iOS apps

Comments

Engage with the subscriber community

Premium Newsletters

The best newsletters in Asia, delivered straight to your inbox

Questions?

What is The Ken?

The Ken is a subscription-only business journalism website and app that provides coverage across two editions - India and Southeast Asia.

What kind of stories do you write?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics.

We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

What do I get if I subscribe?

For subscribers of the India edition, we publish a new story every weekday, a premium daily newsletter, Beyond The First Order and a weekly newsletter - The Nutgraf.

FFor subscribers of the Southeast Asia edition, we publish a new story three days a week and a weekly newsletter, Strait Up.

The annual subscription will get you complete, exclusive access to our archive of previously published stories for your edition, along with access to our subscriber-only mobile apps, our premium comment sections, our newsletter archives and several other gifts and benefits.

Do I need to pay separately for your premium newsletters?

Nope. Paid, premium subscribers of The Ken get our newsletters delivered for free.

Does a subscription to the India edition grant me access to Southeast Asia stories? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

Do you offer an all-access joint subscription for both editions?

Not yet. If you’d like to access both editions, you’ll have to purchase two subscriptions separately - one for India and the other for Southeast Asia.

Do you offer any discounts?

No. We have a zero discounts policy.

Is there a free trial I can opt for?

We don’t offer any trials, but you can sign up for a free account which will give you access to the weekly free story, our archive of free stories and summaries of the paid stories. You can stay on the free account as long as you’d like.

Do you offer refunds?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Please write to us at [email protected] detailing the error or queries.

GST’s attack on pharma’s weakest link: distribution